Literature DB >> 26925627

Roles of Galectin-7 in Cancer.

Manpreet Kaur1, Tarnjeet Kaur, Sukhdev Singh Kamboj, Jatinder Singh.   

Abstract

Galectins are β-galactoside binding lectins that contain one or more carbohydrate recognition domains. As a consequence of sugar-binding properties, galectins exhibit a variety of interactions with glycoproteins, thus playing important roles in various pathological processes. A number of studies have shown roles of galectins in cancer. Galectin-7 is a prototype member of the galectin family implicated in epithelial stratification and cell migration. It can act as a potent dual regulator in different types of cancer. Galectin-7 may contribute either to neoplastic transformation and tumour progression through regulation of cell growth, cell cycle, angiogenesis, apoptosis and cell migration or may have a protective effect in cancer depending on the tissue type. A perusal of the literature indicates particular roles of galectin-7 in carcinomas and melanomas, while contributions await greater exploration in other types of cancers including sarcomas and leukemia. This review collectively summarizes available literature on expression and roles of galectin-7 in different cancers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26925627     DOI: 10.7314/apjcp.2016.17.2.455

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  13 in total

1.  Cyanobacterial bioactive compound EMTAHDCA recovers splenomegaly, affects protein profile of E. coli and spleen of lymphoma bearing mice.

Authors:  Shashank Kumar Maurya; Balkrishna Tiwari; Sindhunath Chakraborty; Ekta Verma; Rajnikant Mishra; Arun Kumar Mishra
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

2.  Galectin-7 is elevated in endometrioid (type I) endometrial cancer and promotes cell migration.

Authors:  Ellen Menkhorst; Meaghan Griffiths; Michelle Van Sinderen; Kate Rainczuk; Keith Niven; Evdokia Dimitriadis
Journal:  Oncol Lett       Date:  2018-07-23       Impact factor: 2.967

Review 3.  Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.

Authors:  Kamil Wdowiak; Tomasz Francuz; Enrique Gallego-Colon; Natalia Ruiz-Agamez; Marcin Kubeczko; Iga Grochoła; Jerzy Wojnar
Journal:  Int J Mol Sci       Date:  2018-01-10       Impact factor: 5.923

Review 4.  Galectin-7 in Epithelial Homeostasis and Carcinomas.

Authors:  Tamara Advedissian; Frédérique Deshayes; Mireille Viguier
Journal:  Int J Mol Sci       Date:  2017-12-19       Impact factor: 5.923

Review 5.  Targeting cell signaling in allergic asthma.

Authors:  Seyyed Shamsadin Athari
Journal:  Signal Transduct Target Ther       Date:  2019-10-18

6.  DNAJA3/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells.

Authors:  Sheng-Fan Wang; Kuo-Hung Huang; Wei-Chuan Tseng; Jeng-Fan Lo; Anna Fen-Yau Li; Wen-Liang Fang; Chian-Feng Chen; Tien-Shun Yeh; Yuh-Lih Chang; Yueh-Ching Chou; Hung-Hsu Hung; Hsin-Chen Lee
Journal:  Cancers (Basel)       Date:  2020-11-20       Impact factor: 6.639

7.  Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry.

Authors:  Annika Richter; Alexander Fichtner; Jasmin Joost; Hanibal Bohnenberger; Philipp Brockmeyer; Philipp Kauffmann; Henning Schliephake; Alexander Hammerstein-Equord; Stefan Kueffer; Henning Urlaub; Thomas Oellerich; Philipp Ströbel; Felix Bremmer
Journal:  J Pathol Clin Res       Date:  2021-10-14

Review 8.  Functions and Inhibition of Galectin-7, an Emerging Target in Cellular Pathophysiology.

Authors:  Nishant V Sewgobind; Sanne Albers; Roland J Pieters
Journal:  Biomolecules       Date:  2021-11-18

Review 9.  Galectins and Ovarian Cancer.

Authors:  Chisa Shimada; Rui Xu; Linah Al-Alem; Marina Stasenko; David R Spriggs; Bo R Rueda
Journal:  Cancers (Basel)       Date:  2020-05-31       Impact factor: 6.639

10.  HSP40 co-chaperone protein Tid1 suppresses metastasis of head and neck cancer by inhibiting Galectin-7-TCF3-MMP9 axis signaling.

Authors:  Yu-Syuan Chen; Ching-Wen Chang; Yeou-Guang Tsay; Liu-Ying Huang; Yi-Chen Wu; Li-Hao Cheng; Cheng-Chieh Yang; Cheng-Hsien Wu; Wan-Huai Teo; Kai-Feng Hung; Chih-Yang Huang; Te-Chang Lee; Jeng-Fan Lo
Journal:  Theranostics       Date:  2018-06-13       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.